Changes in immunoglobulin-nucleoprotein complex structure mapped by chromatin immunoprecipitation

Area of Science:

• Immunology
• Molecular Biology
• Epigenetics

Background:

• Transcription factor (TF) binding to immunoglobulin (Ig) enhancers is crucial for Ig gene activation during B cell development.
• Previous studies often analyzed TF-enhancer interactions outside the physiological context of chromatin.

Purpose of the Study:

• To investigate the in vivo interaction of the Ig enhancer activator PU.1 with Igmu and kappa3' enhancers in murine B cells.
• To understand how chromatin structure and antibody epitope availability affect Chromatin Immunoprecipitation (ChIP) assay results for PU.1.
• To explore the cell-type specificity of PU.1-containing nucleoprotein complexes at Ig enhancers.

Main Methods:

• Chromatin immunoprecipitation (ChIP) using two antibodies targeting different PU.1 epitopes in murine B cells.
• Analysis of PU.1 association with Igmu and kappa3' enhancers in various B cell populations (including RAG1-/- and RAG2-/- cells) and macrophages.
• Quantitative PCR to assess DNA binding and primer efficiency.

Main Results:

• ChIP results for PU.1 association with Ig enhancers are dependent on the accessibility of the targeted epitope, not always reflecting total protein association.
• Nucleoprotein complex structures at Ig enhancers are cell-type specific, as demonstrated by differential PU.1 association in macrophages and specific B cell subsets.
• PU.1 association with the kappa3' enhancer is absent in RAG1-/- pro-B cells, suggesting locus accessibility is critical.

Conclusions:

• The accessibility of epitopes targeted by ChIP antibodies can influence the interpretation of TF binding studies.
• Cellular protein context and chromatin structure dictate the formation and accessibility of nucleoprotein complexes at Ig enhancers.
• ChIP can be utilized to monitor dynamic changes in nucleoprotein complex structure and composition in situ.